Pills for anxiety and sleep problems not linked to increased dementia risk

February 2, 2016, British Medical Journal

Taking benzodiazepines (widely used drugs to treat anxiety and insomnia) is not associated with an increased dementia risk in older adults, finds a study published by The BMJ today.

These results do not support a direct (causal) association between benzodiazepine use and dementia, say the researchers. However, healthcare providers are still advised to avoid benzodiazepines in to prevent important adverse health outcomes.

Benzodiazepines are widely prescribed among older adults to manage sleep, anxiety and depressive disorders. Some studies have suggested that benzodiazepine use could be associated with an increased risk of dementia, but results are conflicting.

Given the enormous public health implications, a better understanding of the potential cognitive risks of cumulative benzodiazepine use is needed.

So a team of US researchers at the University of Washington (UW) and Group Health in Seattle, led by UW Professor of Pharmacy Shelly Gray, set out to determine whether higher cumulative use of benzodiazepines is associated with a higher risk of dementia or more rapid cognitive decline

Their study involved 3,434 participants at Group Health aged 65 and older without dementia at study entry, who were followed for an average of seven years.

Cognitive screening was carried out when participants entered the study and again every two years. Benzodiazepine use was assessed using computerised pharmacy data over a 10 year period.

Factors such as age, sex, and presence of other conditions were recorded and participants were asked about smoking, exercise and self-rated health.

Longitudinal observational studies, such as this, do not show cause and effect, but can be used to explore the relationship between benzodiazepine use and risk of dementia over time.

During follow-up, 797 participants (23%) developed dementia, of whom 637 (80%) developed Alzheimer's disease.

The team found no association between the highest level of benzodiazepine use (the median level of use in this group was equivalent to about one year of daily use) and dementia or cognitive decline.

Contrary to expectations, they found a small increased risk for dementia in people with low (up to one month) or moderate (one to four months) use. However, suggest this could represent treatment of prodromal [early] symptoms."

They also point to some study limitations and say they were unable to completely rule out potential bias that could have affected their results.

"Overall, our results do not support a causal association between benzodiazepine use and dementia," they write. Nonetheless, given the mixed evidence regarding benzodiazepines and risk of dementia and that these drugs are associated with many adverse events, "healthcare providers are still advised to avoid in older adults to prevent important adverse health outcomes, withdrawal and dependence," they conclude.

In 2015, this same team published findings showing a link between the heavy use of medications with anticholinergic activity (including some over the counter sleep aids and allergy medications, and tricyclic antidepressants) and .

Explore further: Long-term use of pills for anxiety and sleep problems may be linked to Alzheimer's

More information: Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study, BMJ, www.bmj.com/cgi/doi/10.1136/bmj.i90

Related Stories

Long-term use of pills for anxiety and sleep problems may be linked to Alzheimer's

September 9, 2014
Taking benzodiazepines—widely prescribed drugs to treat anxiety and insomnia—is associated with an increased risk of developing Alzheimer's disease, particularly for long-term users, suggests a study published in BMJ ...

Diabetes, heart disease, smoking increase risk of death for older adults with dementia

January 27, 2016
Dementia (a decline in memory and other mental abilities) is a serious condition, and its prognosis (the likely course of the disease) is marked by progressive loss of cognitive function and complications such as infections ...

Over 65s at increased risk of developing dementia with benzodiazepine

September 27, 2012
Patients over the age of 65 who begin taking benzodiazepine (a popular drug used to treat anxiety and insomnia) are at an approximately 50% increased risk of developing dementia within 15 years compared to never-users, a ...

Benzodiazepines ineffective in treating anxiety disorders and may increase dementia risk

October 5, 2015
Patients taking benzodiazepines to treat psychiatric conditions should consider transitioning to other therapies because of heightened risks for dementia and death, according to clinicians from the American College of Osteopathic ...

Use of anticholinergic drugs does not increase risk for dementia in Parkinson's disease patients

January 4, 2016
Recent evidence has shown a greater risk of dementia, in particular Alzheimer's disease (AD), in individuals using anticholinergic medications regularly. These drugs are widely used by older adults to treat bladder dysfunction, ...

Despite risks, benzodiazepine use highest in older people

December 17, 2014
Prescription use of benzodiazepines—a widely used class of sedative and anti-anxiety medications—increases steadily with age, despite the known risks for older people, according to a comprehensive analysis of benzodiazepine ...

Recommended for you

Neuroimaging study reveals 'hot spot' for cue-reactivity in substance-dependent population

November 20, 2018
When patients with dependence on alcohol, cocaine or nicotine are shown drug cues, or images related to the substance, an area of their brain known as the medial prefrontal cortex (mPFC) shows increased activity, report investigators ...

Being fair: The benefits of early child education

November 20, 2018
Children from low-income families who got intensive education early in life treat others with high levels of fairness in midlife, more than 40 years later, even when being fair comes at a high personal cost, according to ...

Does Netflix's '13 Reasons Why' influence teen suicide? Survey asks at-risk youths

November 20, 2018
A significant proportion of suicidal teens treated in a psychiatric emergency department said that watching the Netflix series "13 Reasons Why" had increased their suicide risk, a University of Michigan study finds.

MDMA makes people cooperative, but not gullible

November 19, 2018
New research from King's College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better—but only with trustworthy people. In the first study to look in detail at how MDMA impacts cooperative ...

Exploring the genetic contribution to suicide risk

November 19, 2018
Researchers at University of Utah Health identified four gene changes that occur more frequently in people who died by suicide that may point to increased risk in vulnerable individuals.

Response to daily stressors could affect brain health in older adults

November 19, 2018
Taking typical daily annoyances such as a long wait at the doctor's office or a traffic jam on the freeway in stride may help preserve brain health in older adults, while emotional reactions could contribute to declines in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.